Scientists showed that downregulation of METTL3 in prostate cancer tumor-associated macrophages modulated macrophages toward an M2-like phenotype and that this modulation was mediated by activation of STAT6.
[International Immunopharmacology]
Sorry, but the selected Zotpress account can't be found.